Direct thrombin inhibitor
Showing 26 - 50 of >10,000
Thrombin Generation by ST Genesia System
Not yet recruiting
- Patients Without a Medical History of Thrombosis or Hemorrhage
- +4 more
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 13, 2022
Registration of Idarucizumab for IntraCranial Hemorrhage
Completed
- Intracranial Hemorrhage
- Dabigatran Etexilate Oral Capsule [Pradaxa]
- +2 more
-
Bad Aibling, Germany
- +32 more
Apr 6, 2022
Acute Respiratory Failure, SARS CoV 2 Infection, Anticoagulants Trial in Catanzaro (Enoxaparin Sodium, Bivalirudin)
Completed
- Acute Respiratory Failure
- +2 more
- Enoxaparin Sodium
- Bivalirudin
-
Catanzaro, ItalyAOU Mater Domini
Aug 17, 2022
Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,
Completed
- Intracranial Hemorrhages
- +8 more
- Apixaban
- +6 more
-
Edinburgh, Midlothian, United Kingdom
- +66 more
Mar 31, 2022
Heart Failure, Volume Overload Trial in Tbilisi (ALFAPUMP DSR (DIRECT SODIUM REMOVAL) SYSTEM, SGLT2 inhibitor)
Recruiting
- Heart Failure
- Volume Overload
- ALFAPUMP DSR (DIRECT SODIUM REMOVAL) SYSTEM
- SGLT2 inhibitor
-
Tbilisi, Georgia
- +1 more
May 27, 2021
Coagulation Disorder Trial in Groningen (VMX-C001, Placebo, Apixaban)
Recruiting
- Coagulation Disorder
- VMX-C001
- +4 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Dec 7, 2021
Heparin-induced Thrombocytopenia Trial in Worldwide (Danaparoid Sodium, Argatroban)
Terminated
- Heparin-induced Thrombocytopenia
- Danaparoid Sodium
- Argatroban
-
Gainesville, Florida
- +34 more
Dec 6, 2022
Chronic Renal Failure Trial in Valinhos (Heparin sodic, heparin liquemine)
Suspended
- Chronic Renal Failure
- Heparin sodic
- heparin liquemine
-
Valinhos, Sao Paulo, BrazilLal Clinica Pesquisa E Desenvolvimento Ltda
Nov 1, 2022
Hemophilia Trial in Tianjin (KN057 dose?, KN057 dose ?, KN057 dose ?)
Recruiting
- Hemophilia
- KN057 doseⅠ
- +2 more
-
Tianjin, Tianjin, China
- +1 more
Jul 20, 2022
EMR Tool Impact on HIT Documentation and Management
Completed
- Heparin
- +2 more
- Electronic medical record order panel and resident involvement
-
Chicago, IllinoisRush University Medical Center
Jun 27, 2022
Success of Inhibitor Elimination Using Individualized
Recruiting
- Haemophilia A
-
Mörfelden-Walldorf, GermanyHaemophilia centre Rhine Main (HZRM)
Aug 31, 2021
Iatrogenic False Femoral Aneurysms by Ultrasound-guided Thrombin
Recruiting
- Femoral; Aneurysm
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 16, 2022
Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)
Completed
- Intracerebral Hemorrhage
- Tranexamic acid
- Saline 0.9%
-
Basel, SwitzerlandStroke Center, University Hospital Basel
Mar 22, 2022
Acute Aortic Dissection, Coagulation Disorder Trial in Aarhus (Acute surgery for aortic dissection type A)
Not yet recruiting
- Acute Aortic Dissection
- Coagulation Disorder
- Acute surgery for aortic dissection type A
-
Aarhus, DenmarkAarhus University Hospital Skejby
Aug 2, 2022
Atrial Fibrillation, Intracerebral Hemorrhage Trial in Germany, Spain, United Kingdom (Apixaban Oral Tablet, Dabigatran,
Recruiting
- Atrial Fibrillation
- Intracerebral Hemorrhage
- Apixaban Oral Tablet
- +3 more
-
Altenburg, Germany
- +27 more
Feb 17, 2021
Central Line Complication, Thrombosis, Venous Trial in Hong Kong (Thrombin generation assay)
Not yet recruiting
- Central Line Complication
- Thrombosis, Venous
- Thrombin generation assay
-
Hong Kong, Hong KongQueen Mary Hospital
Oct 20, 2023
Thrombin Generation Parameters in Patients on ECMO Support:Pilot
Recruiting
- Extracorporeal Circulation; Complications
- Extracorporeal Membrane Oxygenation Complication
- DIC markers and Thrombin Generation Parameters
-
Hong Kong, Hong KongQueen Mary Hospital
Oct 18, 2023
Liver Transplant; Complications Trial in Warsaw (TachoSil)
Recruiting
- Liver Transplant; Complications
-
Warsaw, Mazovian Voivodeship, PolandDepartment of General Transplant and Liver Surgery
Nov 3, 2023
![](/image/sponsor/azienda_ospedaliera_universitaria_policlinico_"g_martino")
Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor
Not yet recruiting
- Dual Antiplatelet Therapy
- +2 more
- P2Y12 inhibitor de-escalation
-
Messina, Italy
- +1 more
Jun 12, 2023
Platelet Aggregation, Spontaneous, Coronary Artery Disease Trial in São Paulo (Colchicine 0.5 MG, Placebo)
Recruiting
- Platelet Aggregation, Spontaneous
- Coronary Artery Disease
- Colchicine 0.5 MG
- Placebo
-
São Paulo, Sao Paulo, BrazilHeart Institute (InCor) / University of São Paulo
Jul 18, 2023
Respiratory Failure Trial in Beijing (Argatroban, unfractionated heparin)
Recruiting
- Respiratory Failure
- Argatroban
- unfractionated heparin
-
Beijing, Beijing, ChinaBing Sun
Nov 8, 2022
Non-alcoholic Fatty Liver Disease Trial in Pozzilli (nutraceutical mixture, )
Completed
- Non-alcoholic Fatty Liver Disease
- nutraceutical mixture
- placebo
-
Pozzilli, Isernia, ItalyIRCCS Neuromed
Jan 11, 2022
CytoSorb® Filter to Remove Anticoagulants From Circulation
Recruiting
- Aortic Dissection
- Factor X Inhibition
-
Oslo, NorwayOslo University Hospital
Jan 31, 2022
Plasminogen Deficiency Trial in Saskatoon (Aliquoted allogeneic donor plasma in patient's conjunctiva)
Not yet recruiting
- Plasminogen Deficiency
- Aliquoted allogeneic donor plasma in patient's conjunctiva
-
Saskatoon, Saskatchewan, CanadaUniversity of Saskatchewan
Nov 7, 2022